| Literature DB >> 33012868 |
Praveen Rishi1, Khemraj Thakur1, Shania Vij1, Lavanya Rishi2, Aagamjit Singh3, Indu Pal Kaur4, Sanjay K S Patel5, Jung-Kul Lee5, Vipin C Kalia5.
Abstract
Worldwide, millions of individuals have been affected by the prevailing SARS-CoV-2. Therefore, a robust immune system remains indispensable, as an immunocompromised host status has proven to be fatal. In the absence of any specific antiviral drug/vaccine, COVID-19 related drug repurposing along with various other non-pharmacological measures coupled with lockdown have been employed to combat this infection. In this context, a plant based rich fiber diet, which happens to be consumed by a majority of the Indian population, appears to be advantageous, as it replenishes the host gut microbiota with beneficial microbes thereby leading to a symbiotic association conferring various health benefits to the host including enhanced immunity. Further, implementation of the lockdown which has proven to be a good non-pharmacological measure, seems to have resulted in consumption of home cooked healthy diet, thereby enriching the beneficial microflora in the gut, which might have resulted in better prognosis of COVID-19 patients in India in comparison to that observed in the western countries. © Association of Microbiologists of India 2020.Entities:
Keywords: Association; COVID-19; Diet; Dysbiosis; Gut microbiota; Symbiosis
Year: 2020 PMID: 33012868 PMCID: PMC7521193 DOI: 10.1007/s12088-020-00908-0
Source DB: PubMed Journal: Indian J Microbiol ISSN: 0046-8991 Impact factor: 2.461
Fig. 1a Confirmed COVID-19 cases in different countries on 31st May, 2020; b Comparative fatality rate of COVID-19 infection and cases per lakh population; c Cumulative cases (confirmed, recovered and deceased) in India during different phases of Lockdown.
[Graph generated from the data retrieved from (http://www.covid19india.org) by using R script]
Fig. 2Schematic representation of possible association of diet derived microbiota with susceptibility to/clinical outcome of COVID-19